ES399033A1 - A procedure for the preparation of new complexes of polypeptide inorganic silicate hormones equipped with prolonged and increased hormonal activity. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the preparation of new complexes of polypeptide inorganic silicate hormones equipped with prolonged and increased hormonal activity. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES399033A1
ES399033A1 ES399033A ES399033A ES399033A1 ES 399033 A1 ES399033 A1 ES 399033A1 ES 399033 A ES399033 A ES 399033A ES 399033 A ES399033 A ES 399033A ES 399033 A1 ES399033 A1 ES 399033A1
Authority
ES
Spain
Prior art keywords
prolonged
translation
preparation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES399033A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES399033A1 publication Critical patent/ES399033A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

A process for the preparation of new hormonal complexes of inorganic silicate polypeptides endowed with prolonged and increased activity of natural or synthetic origin, with a structure similar to natural or different, whose procedure is characterized in that the peptides and/or polypeptides and/or or proteins and/or their derivatives and/or the salts of these biologically active compounds are contacted with inorganic silicon compounds formed, at least in part, by silicon-oxygen bonds, preferably with silicon dioxide and/or silicic acid and/or a polysilicic acid and/or with the salts of these natural or synthetic compounds. (Machine-translation by Google Translate, not legally binding)
ES399033A 1971-01-20 1972-01-19 A procedure for the preparation of new complexes of polypeptide inorganic silicate hormones equipped with prolonged and increased hormonal activity. (Machine-translation by Google Translate, not legally binding) Expired ES399033A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (1)

Publication Number Publication Date
ES399033A1 true ES399033A1 (en) 1975-05-16

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
ES399033A Expired ES399033A1 (en) 1971-01-20 1972-01-19 A procedure for the preparation of new complexes of polypeptide inorganic silicate hormones equipped with prolonged and increased hormonal activity. (Machine-translation by Google Translate, not legally binding)

Country Status (10)

Country Link
AU (1) AU3784072A (en)
BE (1) BE778239A (en)
CA (1) CA972288A (en)
DD (1) DD98915A5 (en)
DE (1) DE2202176A1 (en)
ES (1) ES399033A1 (en)
FR (1) FR2122529A1 (en)
IL (1) IL38546A0 (en)
NL (1) NL7200716A (en)
ZA (1) ZA72252B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (en) * 1972-10-12 1981-01-27
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE3230736A1 (en) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht ACTIVE SUBSTANCES BONDED TO SILICON DIOXIDE, METHOD FOR THEIR PRODUCTION AND THEIR USE
DE3502099A1 (en) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold THERAPEUTIC, PEPTIDE AND / OR AMINO ACID CONTAINER
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758B1 (en) * 1999-10-15 2002-05-17 Exsymol Sa COMPLEX BASED ON BIOLOGICALLY ASSIMILABLE ORTHOSILICIC ACID, IN SOLID, STABLE AND CONCENTRATED FORM, AND PREPARATION METHOD

Also Published As

Publication number Publication date
FR2122529A1 (en) 1972-09-01
BE778239A (en) 1972-05-16
DD98915A5 (en) 1973-07-12
AU3784072A (en) 1973-07-19
NL7200716A (en) 1972-07-24
IL38546A0 (en) 1972-03-28
ZA72252B (en) 1972-09-27
DE2202176A1 (en) 1972-08-03
FR2122529B1 (en) 1975-12-26
CA972288A (en) 1975-08-05

Similar Documents

Publication Publication Date Title
ES323049A1 (en) A method to improve the quality of nutritive substances containing proteins. (Machine-translation by Google Translate, not legally binding)
IL39953A (en) Process for the preparation of increased yields of polypeptide and a protein beverage
NO139633C (en) PROCEDURE FOR AA REDUCE THE CONTENT OF NITROUS GASES IN NITROSE GASES
IT1036606B (en) PLAN INTENDED FOR THE PNEUMATIC TRANSPORT OF GARMENTS
IT957925B (en) IMPROVEMENT IN VALVES FOR NEBULIZERS
ZA723168B (en) Carrier-bound protein and process for its preparation
ES399033A1 (en) A procedure for the preparation of new complexes of polypeptide inorganic silicate hormones equipped with prolonged and increased hormonal activity. (Machine-translation by Google Translate, not legally binding)
BE802099A (en) PROCESS FOR THE PREPARATION OF PROTEINS AND ACTIVE PEPTIDES OF TUBERCULIN
ES206128U (en) Flat doll or doll of head and articulated extremities. (Machine-translation by Google Translate, not legally binding)
SE386664B (en) PROCEDURE FOR PREPARING CYSTINAL PEPTIDES
ES418158A1 (en) Peptides of acth activity containing alpha-aminooxy carboxylic acids on both terminals and a process for the preparation thereof
ZA725852B (en) Improvements in or relating to internal bead trimmers
GB1388227A (en) Amino-acid salts of sulphoglycopeptides
ES417951A1 (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof
IL38974A0 (en) Production of soluble protein
BE783480A (en) HIGH PROTEIN EGG SUCCEDANE
IL36482A0 (en) The manufacture of natural amino acid mixtures from protein material
SE386358B (en) PROCEDURE FOR THE PRODUCTION OF NATURAL PROTEIN FIBERS OF ANIMAL ORIGIN
AU449008B2 (en) Manufacture of natural amino acid mixtures from protein materials
AU469956B2 (en) Improvements in and relating to leg clamps for animals
CA869067A (en) Method for reducing amino acids and amino-acid derivatives containing disulphide bridges
AU2734271A (en) Manufacture of natural amino acid mixtures from protein materials
GB959747A (en) Process of preparing casein glue
ES238159A1 (en) A process to prepare a stable aquamic prepared of calcium anfomycin (Machine-translation by Google Translate, not legally binding)
AU454064B2 (en) Improvements relating to dosing apparatus anda valve therefor